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Summary Visual inspection of the uterine cervix by paramedical personnel has been proposed for the early detection of cervical cancer, as
an alternative to routine cytology screening in developing countries. We evaluated the performance of this procedure in detecting precursor
lesions and cancer in a study involving 2843 married women in Kerala, India. Two thresholds were used to define a positive test. In the lower
one, any abnormality was considered as positive. The cut-off point for the high threshold was one or more of the high-risk findings: bleeding
on touch, suspicious growth/ulcer and hard, irregular, oedematous cervix. A Pap smear was performed on all subjects, and abiopsy was done
for those with moderate dysplasia and above. A combination ofcytology and histology findings was used as the 'gold standard'. Using the low
threshold, 1279 (45%) women were positive on visual inspection, and with the higher threshold 179 (6.3%) were positive. There were six
moderate dysplasias, nine severe dysplasias, ten carcinomas in situ and 13 invasive carcinomas. With the lower threshold, sensitivity and
specificity to detect moderate dysplasia and above were 65.8% and 55.3% respectively; the values for severe dysplasia and above were
71.9% and 55.3% respectively and for invasive cancer were 92.3% and 55.2% respectively. With the higher threshold, the sensitivity
decreased considerably (28.9% to detect moderate dysplasia lesions, 31.3% for severe dysplasia and 53.8% for clinical cancer) and the
specificity increased to approximately 94%. At a lower threshold, the sensitivity was not satisfactory, and the test was highly non-specific; at
a higher threshold sensitivity was even lower. Thus, the test characteristics of visual inspection are not very promising either as a preselection
procedure for cytology or as a low-technology measure for cervical cancer screening in developing countries.
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The success of screening for cancer depends on the performance
ofthe screening test (test validity), the programme validity and the
adequacy ofhealth services. The purpose ofthe screening test is to
distinguish subjects who probably have a disease from those who
probably do not. The screening test itself is not expected to be
diagnostic; the positive findings need to be evaluated by further
diagnostic procedures (Wilson and Jungner, 1968). Before using a
screening test in an intervention trial or a programme, adequate
information on its validity is necessary.
Visual inspection of the uterine cervix by nurses and other
paramedical health workers has been proposed for the early detec-
tion of cervical cancer, as an alternative to routine Pap smear
screening, in the context of approaches to cervical cancer control
in developing countries (Miller, 1992). This active attempt to
detect disease in an early stage is based on the assumption that
organized cervical cytology screening programmes are not
feasible in many developing countries because of labour and
resource constraints (WHO, 1986).
However, only very limited information is available on the
performance of visual inspection as a screening test. In this paper,
we address the validity of cervical visual inspection in detecting
precursor lesions and cancer, using two different sets ofcriteria to
define a positive visual inspection, and we discuss whether it could
be used as a cost-saving measure to preselect women for cytology.
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MATERIALS AND METHODS
This study was carried out by recruiting women in 30 different
locations in the state of Kerala, India. Health education on
early symptoms of cervical cancer was carried out by trained
voluntary health workers, as part of a cancer awareness programme
conducted by the Community Oncology Division of the Regional
Cancer Centre (RCC), Trivandrum, India. Married women aged 30
years and above, particularly those with symptoms suggestive of
cervical cancer or precursors, were encouraged by the workers to
attend the detection clinics organized as part of the awareness
campaign.
Women attending the clinics were interviewed by trained
cytotechnicians using a structured proforma to elicit information
on sociodemographic factors and reproductive and clinical history.
They were subjected to visual inspection of the cervix and a
routine Pap smearby one trained female cytotechnician supervised
by a doctor. The health workers were trained at RCC to perform
visual examination of the cervix, to distinguish the different
clinical appearances and to take a cervical smear.
Visual inspection was carried out, without magnification, using
a Kusko's self-retaining speculum under adequate light directed
from an electric lamp. The visual appearance of the cervix was
recorded as one or more of the following categories: unhealthy
cervix, cervicitis, hypertrophied cervix, congestion, polyp,
discharge, prolapse, bleeding on touch, suspicious growth/ulcer
and hard, indurated, irregular, oedematous cervix. If none of the
above findings was present, the appearance was recorded as
normal. Women with one or more ofthe following abnormal find-
ings were considered to be at high risk for cancer: bleeding on
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Table 1 Subject characteristics
Characteristic Number (%)
Age in years
<30 332 (11.7)
30-39 986 (34.7)
40-49 629 (29.2)
50-59 408 (14.4)
60 + 288 (10.0)
Residence
Rural 198 (7.0)
Urban 2645 (93.0)
Income
<1000 INR 2596 (91.3)
1000 + 247 (8.7)
Occupation
Housewife 1992 (70.1)
Unskilled labourers 785 (27.6)
Office work 66 (2.3)
Education
Illiterate 612 (21.5)
Primary grade 1608 (56.6)
High school 552 (19.4)
College + 71 (2.5)
Religion
Hindu 1500 (52.8)
Christian 930 (32.97)
Muslim 405 (12.2)
Others 8 (0.03)
Age at marriage (years)
<14 412 (14.5)
15-20 1860 (65.4)
20 + 571 (20.1)
Number of pregnancies
Nil 36 (1.3)
1-2 662 (23.2)
3-4 1150 (40.5)
> 4 995 (35.0)
touch, suspicious growth, suspicious ulcer and hard, indurated,
irregular, oedematous cervix. The other abnormal findings were
considered to indicate low probability ofdetecting cervical cancer
or its precursors.
Two thresholds were used to define a positive visual inspection.
Within the low threshold, any abnormality was considered as a
positive test; the cut-off point for the high threshold was one or
more ofthe high-risk findings.
One cervical smear was taken for each person using a wooden
Ayre's spatula. Endocervical brush was not used in taking smears
as this was not available. The smears fixed in ethyl alcohol were
stained by the Papanicolaou technique, and the readings were
made at the cytology laboratory in the RCC. This is a reference
laboratory recognized by the Indian Academy of Cytologists
(IAC) where cytotechnologists and cytotechnicians are trained.
The cytological findings were reported as follows: normal, inflam-
matory, infection, mild dysplasia, moderate dysplasia, severe
dysplasia, carcinoma in situ and invasive cancer.
Those identified with severe dysplasia, carcinoma in situ and
invasive cancer were further subjected to gynaecological examina-
tion, biopsy and treatment. As colposcopy was not available in the
RCC during the study period, it was not performed in any of the
Table 2 Comparisons of visual inspection findings with cytology results
Visual inspection findings
Pap smear report Normal (%) Low risk (%) High risk (%)
Normal 376 (24.0) 82 (7.5) 5 (2.1)
Inflammation 1007 (64.4) 823 (74.1) 139 (77.7)
Autolytic atrophy 20 (1.3) 0 1 (0.6)
Infection 53 (3.4) 107 (9.7) 13 (7.0)
Mild dysplasia 94 (6.0) 72 (6.6) 12 (6.1)
Moderate dysplasia 6 (0.4) 2 (0.2) 2 (2.1)
Severe dysplasia 2 (0.4) 5 (0.5) 0
Carcinoma in situ 6 (0.4) 2 (0.2) 2 (2.1)
Invasive Cancer 0 5 (0.5) 7 (3.1)
Total 1564 (55.0) 1100 (38.7) 179 (6.3)
study participants. A combination of Pap imear and histology
findings were used as the 'gold standard' in this study to assess the
sensitivity and specificity ofvisual inspection.
RESULTS
A total of 2843 married women attended the detection clinics
(Table 1). Although only women aged 30 years or more were
encouraged to participate, some younger wome'n who attended the
clinics were also included in the study. Most of the women
belonged to the low socioeconomic category. One-fifth of the
women had either school or collegiate education, four-fifths were
married at 20 years orearlier,and three quarters had more than two
children.
The results of visual inspection and cytology are given in Table
2: 1564 (55%) women had normal-looking cervices; 1100 (38.7%)
had an appearance suggesting low-risk findings and the rest
(6.3%) had features suggesting high-risk categories. Thus, using
the lower threshold, 1279 (45%) women had a positive visual
inspection finding whereas with the higher threshold, only 179
(6.3%) had a positive visual screening test.
The cytology results revealed that 178 (6.2%) women had mild
dysplasia, ten (0.4%) had moderate dysplasia; seven (0.2%) had
severe dysplasia and 22 (0.8%) had either carcinoma in situ or
invasive carcinoma.
Biopsies were performed in 36 of 39 subjects with lesions of
moderate dysplasia and above on cytology; three subjects did not
comply with biopsy and further investigations. The cytology and
histology findings were in agreement in 30 subjects; a higher cate-
gory was diagnosed histologically in five. The stage distribution of
invasive cancers was: three cases in stage IB, one in IIA, four IIB,
three IIIB and one stage IVB. One quarter (8/32) of those with
severe dysplasia or above lesions on histology/cytology did not
comply with further treatment. Others with severe dysplasia/carci-
noma in situ were treated with either conization or hysterectomy;
those with invasive cancers were treated with radiotherapy.
Tables 3 and 4 present the frequencies of subjects classified as
positive and negative on visual inspection, according to results on
cytology/histology. When both the low- and high-risk categories
on visual inspection were considered as positive and (lesions) of
moderate dysplasia and above were considered as true positive,the
sensitivity was 65.8% (95% CI 50.2-79.8), specificity 55.3%
(95% CI 53.5-57.1) and positive predictive value (PPV) 2%.
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Table 3 Contingency tables for comparing results of visual inspection and
cytology/histology. (A positive screening test includes both low-and high-risk
findings)
Cytology/histology
Visual inspection Positive Negative Total
True positive lesions - moderate dysplasia and abovea
Positive 25 1254 1279
Negative 13 1551 1564
Total 38 2805 2843
True positive lesions - severe dysplasia and aboveb
Positive 23 1256 1279
Negative 9 1555 1564
Total 32 2811 2843
aSensitivity, 65.8% (95% Cl, 50.2-79.8); specificity, 55.3% (95% Cl,
53.5-57.1); positive predictive value, 2.0%. bSensitivity, 71.9% (95% Cl
55.3-85.8); specificity, 55.3% (95% Cl 53.5-57.2); positive predictive
value, 1.8%.
Table 4 Contingency tables for comparing results of visual inspection and
cytology/histology (Positive screening test includes high-risk category only)
Cytology/histology
Visual inspection Positive Negative Total
True positive lesions- moderate dysplasia and abovea
Positive 11 168 179
Negative 27 2637 2664
Total 38 2805 2843
True positive lesions - severe dysplasia and aboveb
Positive 10 169 179
Negative 22 2642 2664
Total 32 2811 2843
aSensitivity, 28.9% (95% Cl, 15.8-44.2); specificity, 94.0% (95% Cl,
93.1-94.9); positive predictive value, 6.2%. bSensitivity, 31.3% (95% Cl
16.6-48.1); specificity, 93.9% (95% Cl 93.0-94.7); positive predictive
value, 5.6%.
Table 5 Cases of severe dysplasia/carcinoma in situ and invasive cancer by
risk category as assessed by visual inspection
Visual inspection Cytology/histology
Severe dysplasia/carcinoma in situ Invasive cancer
Low threshold
Positive 11 12
Negative 8 1
High threshold
Positive 3 7
Negative 16 6
Total 19 13
Sensitivity of visual inspection increased to 71.9% (95% CI
55.3-85.8) without change in specificity when lesions of severe
dysplasia and above were considered as true positive (Table 3).
When the visual inspection categorized only 'high-risk' lesions
as positive (Table 4) the sensitivity decreased to 28.9% (95% CI
15.8-44.2) for moderate dysplasia and above lesions and 31.3%
(95% CI 16.6-48.1) for severe dysplasia and above lesions. The
specificity increased to 93.9% (95% CI93.0-94.7).
For the detection of clinical cancer, the sensitivity of visual
inspection with the lowerthreshold was 92.3% (95% CI 72.4-100);
specificity and the positive predictive values were 55.2% (95% CI
53.4-57.1) and 9.4% respectively. With the high threshold for a
positive visual inspection, these figures were 53.8% (95% CI
27.5-79.1),93.9% (95% CI 93.0-94.8) and 3.9% respectively.
Table 5 shows the number of subjects detected with severe
dysplasia, carcinoma in situ and invasive cancer by cytology/
histology (true positive lesions) and the proportion ofthese lesions
detected by visual inspection, using the two different thresholds of
positivity. Using the lower threshold, visual screening detected
92% of invasive lesions and 58% of precursor lesions; with the
higher threshold, 54% of the invasive cancers and 16% ofprecur-
sors were detected.
DISCUSSION
Uterine cervical cancer, the most common cancer among women
in developing countries, accounted for 437 000 cases worldwide
in 1985, 80% ofwhich occurred in developing countries (Parkin et
al, 1993), where they are diagnosed mainly in advanced stages.
Although cervical cytology screening programmes have resulted
in the reduction of cervical cancer incidence and mortality in
developed countries, the implementation ofsuch programmes on a
comprehensive and systematic basis has proved very difficult in
developing countries (Parkin et al, 1991).
Alternative methods to regular and periodic cytology screening
have been suggested for implementation in developing countries.
These include low-intensity cytology (WHO, 1986; Prabhakar,
1992a, b; Murthy et al, 1993), naked eye inspection of the cervix
(unaided visual inspection) (Stjernsward et al, 1987; Miller, 1992)
and visual inspection with simple magnifying devices (gynoscopy)
(Sherris et al, 1993). The relative efficacy of these various proce-
dures in detecting cervical cancer and precursors has not yet been
clearly established.
All the previous published studies on unaided visual inspection
have been from India and involved symptomatic patients attending
the gynaecology outpatient clinics. In a study involving cytolog-
ical examination of 11 760 women attending gynaecology clinics
in Delhi, 215 prevalent cancers were detected, of which 88 (41%)
had appearances suspicious of cancer (Seghal et al, 1991). Of the
1107 subjects with dysplasia on regular follow-up, 63 progressed
to cancer and 33 (52%) had abnormalities on visual inspection at
the time of detecting malignancy.
Results ofother reported studies from India are given in Table 6.
In a hospital-based study, 5135 of 44 970 (12%) women attending
maternal and child health centres in New Delhi were found to
have bleeding erosions, unhealthy cervix or growth/ulcers on
visual inspection and 149 cancers were found (Singh et al, 1992).
The sensitivity and specificity of visual inspection to detect inva-
sive cancer were 62.6% and 87.7% respectively. In another
hospital-based study from Delhi, involving 3608 women attending
the gynaecology outpatient clinic, the sensitivity and specificity of
visual inspection to detect all grades of dysplasia, atypia and
malignancy on cervical cytology were 92.5% and 37.1% respec-
tively (Bharghava et al, 1993). In a study involving 3602 sympto-
matic and referred women at an early cancer detection centre in
Ernakulam, Kerala, the sensitivity and specificity were 92.6% and
37.7% respectively (Sujathan et al, 1995).
The above studies predominantly addressed the feasibility of
using paramedical workers to perform speculum examinations and
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Table 6 Results from other studies on the validity of visual inspection
Reference Visual inspection Cytology/biopsy findings Sensitivity (%) Specificity (%)
findings Positive Negative
Singh et al (1992) Positive 149 4986 62.6 88.9
Negative 89 39 746
Bhargava et al (1993) Positive 184 2145 92.5 37.1
Negative 15 1264
Sujathan et al (1995) Positive 75 2192 92.6 37.7
Negative 6 1329
assessed their capability to identify abnormal cervices and to take
Pap smears. The high sensitivity observed in two of the reports is
likely to be due to the selected and the symptomatic population
studied. A low specificity has been consistently reported.
However, the implications ofthe poor test characteristics were not
discussed in these studies.
The present investigation, which involved both symptomatic
and asymptomatic individuals, is not a true community-based
study. Two thresholds were used to define a positive test to eval-
uate their effect on the test performance. At a lower threshold of
positive visual inspection, the sensitivity was not satisfactory and
the test was highly non-specific: the specificity was around 55%.
In a setting without facilities for cytology, this would entail
recalling 45% of the screened women for examination by gynae-
cologists. At a high threshold of positive visual inspection, the
sensitivity for detecting lesions was even lower.
If one considers cost saving as a major consideration in using
low-technology methods in cervical cancer control, unaided visual
inspection is unlikely to achieve this objective. If it is used for
preselecting women for cytology, the costs saved pertain to not
offering Pap smears to women with apparently healthy cervices
(approximately 50%). Costs are involved in locating, inviting
women for pelvic examination, further referrals and investiga-
tions. Results of cost evaluation of cervical cytology programmes
in the Netherlands indicate that co-ordination, invitation, pelvic
examination and registration account for 55% of costs, and cyto-
logical evaluation accounts for 45% (Koopmanschap et al, 1990).
As the test is highly unsatisfactory at a high threshold, the lower
threshold would entail 45% of the women being recalled, offered
Pap smear, and further investigations (colposcopy, biopsy) would
be needed in a significant proportion of the women called for
Pap smear. At the same time, the low sensitivity would result in at
least one third of women with high grade lesions being missed.
The need to repeat the visual inspection at periodic intervals
would also entail costs. Thus, cost savings are unlikely to be
substantial, added to the low efficacy to detect precursor and inva-
sive lesions.
In settings where facilities for even limited cytology do not
exist, visual inspection would necessitate halfof the women being
further examined by gynaecologists, resulting in overcrowding of
services.
There might be a concern that some of the false positives on
visual inspection are really true positives, misclassified by the
results of cytology, and may be responsible for the low specificity
and positive predictive value. The Pap smear is admittedly an
imperfect screening test with a significant error rate and a wide
range of values for sensitivity and specificity in different settings
(Shingleton et al, 1995). However, subjects with negative findings
on visual inspection may also be misclassified by cytology, and so
it is unlikely that sensitivity has been markedly underestimated.
Another concern with visual inspection is the objectivity of the
positive test. A screening test should be as objective as possible.
Even though defined criteria exist for an abnormal visual finding,
the possibility ofa subjective decision on the part ofthe examiners
cannot be ruled out. Even after rigorous training, this may result in
considerable fluctuations in the validity of unaided visual inspec-
tion as a screening test.
It is worthwhile investigating adjuvants to visual inspection. For
example, visual examination of 3-5% acetic acid impregnated
cervix with the use ofa magnifying device (gynoscopy) or without
magnification (cervicoscopy) may improve the objectivity and
performance of unaided visual inspection. Acetic acid visualiza-
tion of the cervix (cervicoscopy) has been shown to detect
dysplasia, otherwise missed by cervical cytology. A report from
Italy (Ceccini et al, 1993) indicated a higher sensitivity of cervi-
coscopy to detect high-grade lesions than the use of Pap smear,
though specificity was lower. Cervicoscopy, therefore, merits
evaluation as a screening test.
In summary, the test characteristics ofunaided visual inspection
are not very promising as a preselection procedure for cytology or
as a low technology measure for cervical cancer screening. A
reasonable proportion of preinvasive lesions can only be found
when large numbers ofthose examined are classified as 'positive'.
Implementation of a public health policy, based on unaided visual
inspection for cervical cancer control, is unlikely to be cost-effec-
tive and, in the long run, it may prove to be more expensive than a
limited cytology programme.
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